Guess what is the total percentage of dalit or tribal members in the boards of big Indian private and public sector companies listed on the stock exchange? Well, shocking as it might be, the real count is nearly zero. A fresh study conducted by D Ajit, Han Donker and Ravi Saxena reveals that at a time when the issues of ethnic and racial inequalities is being discussed all over the world,...

-The Hindu Business Line   Arsenic and fluoride contaminated water has condemned millions to live wasted lives in West Bengal, Andhra Pradesh and Karnataka. Business Line visited several villages in the affected regions for this special report by A. Srinivas. Sixty-nine-year-old Renubala Ari of Deganga village in West Bengal's North 24 Parganas district is counting her last days. But it is not her death that worries her. Blind in both eyes and with painful...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-CNN-IBN Kolkata: The West Bengal chit fund is getting bigger each day. It has now turns out that ponzi schemes in the state financed not just media houses but Tollywood films as well. In the past four years, at least one in three films has been produced by groups that run ponzi schemes. Rose Valley, a deposit-taking company which is now under the MCA scanner, has produced 18 films including three National...

-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...